CAR T-cells: an advancement in treating MM?
How next-generation sequencing will change the treatment of multiple myeloma
Ibrutinib combined with TGR-1202 in CLL and mantle cell lymphoma (MCL): preliminary results
Pembrolizumab: a promising agent for the treatment of MM
How is the landscape of Hodgkin lymphoma therapy changing?